IP Library › Assignment 046047/0201
Patent Assignment
Reel/Frame 046047/0201

Assignment of Assignor's Interest

Recorded: 2018-06-11 Pages: 19
Assignor
Assignee
1096271 B.C. UNLIMITED LIABILITY COMPANY
1200 WATERFRONT CENTRE, 200 BURRARD ST., P.O. BOX 48600, VANCOUVER, BRITISH COLUMBIA, V7X 1T2, CANADA
Covered Properties (2)
Compositions and Methods for Treating Neoplastic Diseases
Patent: 8,722,724 →
Application: 12/183,007 →
Publication: US 2009/0036390
Compositions and Methods for Treating Neoplastic Diseases
Application: 14/224,965 →
Publication: US 2014/0349965
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0850 →
Assignment of Assignor's Interest Jul 17, 2012
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 028618/0860 →
Assignment of Assignor's Interest Jun 24, 2013
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 030670/0412 →
Assignment of Assignor's Interest Oct 10, 2013
From: ANDERSON, KENNETH C.; CHAUHAN, DHARMINDER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 031384/0805 →
Assignment of Assignor's Interest Feb 13, 2017
From: NEREUS PHARMACEUTICALS, INC.
To: TRIPHASE RESEARCH AND DEVELOPMENT I CORP.
Reel/Frame 041698/0404 →
Assignment of Assignor's Interest Jun 8, 2018
From: PALLADINO, MICHAEL A.
To: NEREUS PHARMACEUTICALS, INC.
Reel/Frame 046029/0468 →
Assignment of Assignor's Interest Jun 11, 2018
From: 1096271 B.C. UNLIMITED LIABILITY COMPANY
To: CELGENE TRI A HOLDINGS LTD.
Reel/Frame 046047/0177 →
Assignment of Assignor's Interest Feb 6, 2020
From: CELGENE TRI A HOLDINGS LTD.
To: CELGENE INTERNATIONAL II SARL
Reel/Frame 051741/0848 →
Assignment of Assignor's Interest Feb 6, 2020
From: ANDERSON, KENNETH C.; CHAUHAN, DHARMINDER
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 051743/0203 →